FY27 Revenue: ₹250-260 crore
Full year guidance reaffirmed at ₹250-260 crore versus ₹215 crore in FY26, implying ~20% growth, with Q2 expected to be seasonally soft before recovery in Q3.
INDOBORAXANDCHEMICALS / guidance tracker
Keep management guidance in view.
Indo Borax and · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
FY27 EBITDA Margin: ~20%
Targeting 20% EBITDA margin for full year despite Q1's elevated 28.1%, acknowledging seasonal weakness and raw material cost pass-through limitations.
Indo Borax Capex: ₹50 crore over 2-3 years
₹20 crore for boron oxide (used in fiberglass/steel) and ₹20-25 crore for additional boric acid capacity, with CEO confirming working with consultants on milestones.
DOT Production: 1,500 tonnes in FY27
Production target for sodium octaborate tetrahydrate (agricultural micronutrient), up from 900 tonnes last year, leveraging backward integration from boric acid.